Below are the financial statements of Mankind Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of INR | 2024 | 2023 |
|---|---|---|
| Income | — | — |
| Revenue from operations | 103.35a | 87.49a |
| Other income | 2.81a | 1.29a |
| Total income | 106.16a | 88.78a |
| Expenses | — | — |
| Cost of raw materials and components consumed | -18.54a | -18.14a |
| Purchases of stock-in-trade | -14.1a | -8.09a |
| Changes in inventories of finished goods, work in progress, development rights and stock in trade | -0.54a | -2.91a |
| Employee benefits expense | -22.75a | -19.18a |
| Finance costs | -0.34a | -0.44a |
| Depreciation and amortization expense | -3.98a | -3.26a |
| Other expenses | -23.15a | -20.17a |
| Total expenses | -82.31a | -72.19a |
| Profit before share of net profits from investments accounted for using equity method and tax | 23.84a | 16.59a |
| Share of net profit of associates and joint ventures (net of tax) | 0.15a | 0.12a |
| Profit before tax | 23.99a | 16.71a |
| Tax expense | — | — |
| Current tax | -4.93a | -3.28a |
| Deferred tax | -0.35a | -0.34a |
| Total tax expense | -4.58a | -3.62a |
| Profit for the year | 19.42a | 13.1a |
| Profit for the year attributable to | — | — |
| Equity holders of the parent | 19.13a | 12.82a |
| Non-controlling interests | 0.29a | 0.28a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Mankind Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.